Skip to main content
Krishna Yeshwant

Krishna Yeshwant, M.D.

Managing Partner, GV

Krishna helps steward the GV investing team and co-leads GV’s life sciences group. Krishna led GV’s early investments in Flatiron Health, Foundation Medicine, Relay Therapeutics, Beam Therapeutics, insitro, One Medical, and Aledade. He also established GV’s incubation program, which helped start companies like ROME Therapeutics and Verve Therapeutics.

Krishna was part of a team that helped in the early days of GV’s founding and led the fund’s early commitment to invest in life sciences. Earlier in his career, he helped start an electronic data interchange company acquired by Hewlett-Packard and a network security company acquired by Symantec.

Krishna graduated from Harvard’s M.D./MBA program where he wrote software to use imaging systems to guide surgical procedures. He went on to serve as an attending in internal medicine at Brigham and Women’s Hospital.